The Curious Case Of The Pandemic And AstraZeneca’s Pulmicort In China
Blockbuster Sales Recover As Life Returns To Normal
China’s adherence to face masks to protect against COVID-19 has also helped children avoid other respiratory infections.
You may also be interested in...
Merck’s third quarter beat analyst consensus and the company raised its guidance. The COVID-19-battered vaccines business began to improve but Gardasil’s recovery was slower than expected.
Aiming to mimic public-private COVID-19 vaccine success, the US NIH will fund pandemic drug research, including taking candidates up to Phase II.
Pfizer has unveiled promising results from a study of Xeljanz but needs a bigger trial. Given RECOVERY’s track record, the pharma company may opt to wait for its results.